Injurious effects of lysophosphatidylcholine on barrier properties of alveolar epithelium - PubMed (original) (raw)
Injurious effects of lysophosphatidylcholine on barrier properties of alveolar epithelium
D E Niewoehner et al. J Appl Physiol (1985). 1987 Nov.
Abstract
We studied the effects of lysophosphatidylcholine (lysoPC) on the barrier properties and the morphology of the alveolar-capillary membrane in isolated, fluid-filled hamster lungs continuously perfused. When instilled into the airspace at initial concentrations of 8-128 micrograms/ml, lysoPC causes dose-dependent increases in the permeability-surface area product of the alveolar epithelium for small (14C-sucrose, 342) and large (125I-neutral dextran, 70,000) solutes, with maximal values for each solute approximately 15 times control. Rapid whole-lung weight gains are caused by 128 micrograms lysoPC per milliliter, but each of the lower concentrations has no effect on net lung water balance. Electron-microscopic studies demonstrate that type I pneumonocytes are the lung cells most susceptible to lysoPC exposure, with cell swelling being the most prominent feature from low-dose exposure with more severe disruptive changes at the highest concentration tested. The effects of lysoPC are relatively specific, as several structurally related lipids have little or no effect at equivalent concentrations. Instillation of phospholipase A2 causes functional changes similar to those seen with lysoPC, presumably by generation of lysoPC from endogenous phospholipids. Studies employing a 14C-radiolabeled compound show that instilled lysoPC rapidly partitions into the lung lipid fraction where a major portion of the acyl group becomes incorporated into phosphatidylcholine. The amount of instilled lysoPC required to produce functional and morphological effects comprises only a few percent of total lung phospholipids. Since lysoPC is a normal component of lung phospholipids, severe lung dysfunction might result from minor abnormalities in the formation or degradation of this compound.
Similar articles
- Induction of alveolar epithelial injury by phospholipase A2.
Niewoehner DE, Rice K, Duane P, Sinha AA, Gebhard R, Wangensteen D. Niewoehner DE, et al. J Appl Physiol (1985). 1989 Jan;66(1):261-7. doi: 10.1152/jappl.1989.66.1.261. J Appl Physiol (1985). 1989. PMID: 2917929 - Effects of phospholipase A2 and its hydrolytic products on alveolar epithelial permeability and elastase-induced emphysema.
Rice KL, Duane PG, Niewoehner DE. Rice KL, et al. Am Rev Respir Dis. 1988 Nov;138(5):1196-200. doi: 10.1164/ajrccm/138.5.1196. Am Rev Respir Dis. 1988. PMID: 3264481 - Lysophosphatidylcholine augments elastase-induced alveolar epithelial permeability and emphysema in the hamster.
Rice KL, Duane PG, Niewoehner DE. Rice KL, et al. Am Rev Respir Dis. 1987 Oct;136(4):941-6. doi: 10.1164/ajrccm/136.4.941. Am Rev Respir Dis. 1987. PMID: 3662244 - Lysophosphatidylcholine increases airway and capillary permeability in the isolated perfused rat lung.
Lindahl M, Hede AR, Tagesson C. Lindahl M, et al. Exp Lung Res. 1986;11(1):1-12. doi: 10.3109/01902148609062823. Exp Lung Res. 1986. PMID: 3720691 - Solute conductance of blood-gas barrier in hamsters exposed to hyperoxia.
Wangensteen D, Piper R, Johnson JA, Sinha AA, Niewoehner D. Wangensteen D, et al. J Appl Physiol (1985). 1986 Jun;60(6):1908-16. doi: 10.1152/jappl.1986.60.6.1908. J Appl Physiol (1985). 1986. PMID: 3722060
Cited by
- Basis of rise in intracellular sodium in airway hyperresponsiveness and asthma.
Agrawal A, Agrawal KP, Ram A, Sondhi A, Chhabra SK, Gangal SV, Mehta D. Agrawal A, et al. Lung. 2005 Nov-Dec;183(6):375-87. doi: 10.1007/s00408-005-2549-0. Lung. 2005. PMID: 16465598 - Ventilator-associated pneumonia and atelectasis: evaluation through bronchoalveolar lavage fluid analysis.
Nakos G, Tsangaris H, Liokatis S, Kitsiouli E, Lekka ME. Nakos G, et al. Intensive Care Med. 2003 Apr;29(4):555-63. doi: 10.1007/s00134-003-1680-8. Epub 2003 Feb 21. Intensive Care Med. 2003. PMID: 12595981 - The signal molecule lysophosphatidylcholine in Eschscholzia californica is rapidly metabolized by reacylation.
Schwartze W, Roos W. Schwartze W, et al. Planta. 2008 Dec;229(1):183-91. doi: 10.1007/s00425-008-0819-9. Epub 2008 Sep 20. Planta. 2008. PMID: 18807068 - Novel lysophospholipase A secreted by Legionella pneumophila.
Flieger A, Gong S, Faigle M, Stevanovic S, Cianciotto NP, Neumeister B. Flieger A, et al. J Bacteriol. 2001 Mar;183(6):2121-4. doi: 10.1128/JB.183.6.2121-2124.2001. J Bacteriol. 2001. PMID: 11222614 Free PMC article. - Antigen-induced generation of lyso-phospholipids in human airways.
Chilton FH, Averill FJ, Hubbard WC, Fonteh AN, Triggiani M, Liu MC. Chilton FH, et al. J Exp Med. 1996 May 1;183(5):2235-45. doi: 10.1084/jem.183.5.2235. J Exp Med. 1996. PMID: 8642333 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources